IN2014DN07927A - - Google Patents

Info

Publication number: IN2014DN07927A
Authority: IN; India
Prior art keywords: biorelevant; fasted state; fatty acid; sodium; homogeneous
Prior art date: 2012-03-30

Application number

Other languages

English (en)

Inventor

Mathew Louis Steven Leigh

Steve Leigh

Jennifer Dressman

Bastian Kloefer

Marcel Arndt

Alexander Fuchs

Original Assignee

Phares Pharm Res Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-03-30

Filing date

2013-04-02

Publication date

2015-05-01

2013-04-02 Application filed by Phares Pharm Res Nv filed Critical Phares Pharm Res Nv

2015-05-01 Publication of IN2014DN07927A publication Critical patent/IN2014DN07927A/en

Links

239000000203 mixture Substances 0.000 abstract 3
235000014113 dietary fatty acids Nutrition 0.000 abstract 2
229930195729 fatty acid Natural products 0.000 abstract 2
239000000194 fatty acid Substances 0.000 abstract 2
150000004665 fatty acids Chemical class 0.000 abstract 2
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
241000282472 Canis lupus familiaris Species 0.000 abstract 1
102000004190 Enzymes Human genes 0.000 abstract 1
108090000790 Enzymes Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 abstract 1
239000003833 bile salt Substances 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
230000000968 intestinal effect Effects 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 abstract 1
229940045946 sodium taurodeoxycholate Drugs 0.000 abstract 1
YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 abstract 1
241000894007 species Species 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
- G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility

Landscapes

Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Computational Mathematics (AREA)
Educational Administration (AREA)
Mathematical Analysis (AREA)
Business, Economics & Management (AREA)
Algebra (AREA)
Pure & Applied Mathematics (AREA)
Mathematical Optimization (AREA)
Mathematical Physics (AREA)
Educational Technology (AREA)
Theoretical Computer Science (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Pathology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Investigating Or Analysing Biological Materials (AREA)
Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Fodder In General (AREA)

IN7927DEN2014 2012-03-30 2013-04-02 IN2014DN07927A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12162548.7A EP2645099A1 (fr)	2012-03-30	2012-03-30	Compositions biopertinentes
PCT/EP2013/056945 WO2013144374A1 (fr)	2012-03-30	2013-04-02	Compositions biologiquement pertinentes

Publications (1)

Publication Number	Publication Date
IN2014DN07927A true IN2014DN07927A (fr)	2015-05-01

Family

ID=48143258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN7927DEN2014 IN2014DN07927A (fr)	2012-03-30	2013-04-02

Country Status (11)

Country	Link
US (1)	US20150064794A1 (fr)
EP (2)	EP2645099A1 (fr)
JP (1)	JP6348480B2 (fr)
KR (1)	KR20140144255A (fr)
CN (1)	CN104582689A (fr)
BR (1)	BR112014024256A8 (fr)
CA (1)	CA2867638A1 (fr)
IN (1)	IN2014DN07927A (fr)
MX (1)	MX357927B (fr)
NZ (1)	NZ700064A (fr)
WO (1)	WO2013144374A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY184277A (en) *	2011-08-23	2021-03-30	Kythera Biopharmaceuticals Inc	Formulations of deoxyccholic acid and salts thereof
WO2019199238A1 (fr) *	2018-04-09	2019-10-17	Vet Products Research And Innovation Center Company Limited	Minéral inorganique piégé dans une nanoparticules et son procédé de production
GB201809627D0 (en) *	2018-06-12	2018-07-25	Biorelevant Com Ltd	Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling
GB201904757D0 (en) *	2019-04-04	2019-05-22	Biorelevant Com Ltd	Biorelevant composition
JP2022538628A (ja) *	2019-06-28	2022-09-05	ヤンセンファーマシューティカエヌ．ベー．	生体関連溶出媒体
WO2021165386A1 (fr)	2020-02-19	2021-08-26	Bayer Aktiengesellschaft	Prédiction de propriétés de formulation
GB202112975D0 (en)	2021-09-10	2021-10-27	Biorelevant Com Ltd	Biorelevant dissolution compositions with reproducible spectral profiles
GB202405714D0 (en) *	2024-04-23	2024-06-05	Biorelevant Com Ltd	Biorelevant compositions and media for in vitro testing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4874795A (en) *	1985-04-02	1989-10-17	Yesair David W	Composition for delivery of orally administered drugs and other substances
GB8909022D0 (en) *	1989-04-20	1989-06-07	Cortecs Ltd	Pharmaceutical compositions
US6040188A (en) *	1997-11-18	2000-03-21	The Regents Of The University Of California	In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants
IT1296914B1 (it) *	1997-12-01	1999-08-03	Maria Rosa Gasco	Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
WO2003042392A1 (fr) *	2001-11-15	2003-05-22	Phares Pharmaceutical Research N.V.	Melanges de phospholipides normalises
WO2005092298A1 (fr) *	2004-03-26	2005-10-06	Cell Therapeutics Europe S.R.L.	Preparations de nanoparticules de composes platine
GB0522942D0 (en) *	2005-11-10	2005-12-21	Leigh Steven	Dissolution composition
WO2007085970A2 (fr) *	2006-01-27	2007-08-02	Danisco A/S	Emploi d'une souche de micro-organisme dans le traitement des troubles ponderaux
WO2008040799A2 (fr)	2006-10-06	2008-04-10	Boehringer Ingelheim International Gmbh	Procédé servant à préparer des formes instantanées de solutions micellaires aqueuses mélangées servant de systèmes de tampon physiologique destinés à être utilisés dans l'analyse de la libération in vitro

2012
- 2012-03-30 EP EP12162548.7A patent/EP2645099A1/fr not_active Ceased
2013
- 2013-04-02 EP EP13717734.1A patent/EP2830592A1/fr not_active Withdrawn
- 2013-04-02 BR BR112014024256A patent/BR112014024256A8/pt not_active Application Discontinuation
- 2013-04-02 KR KR1020147030491A patent/KR20140144255A/ko not_active Ceased
- 2013-04-02 US US14/389,701 patent/US20150064794A1/en not_active Abandoned
- 2013-04-02 NZ NZ700064A patent/NZ700064A/en not_active IP Right Cessation
- 2013-04-02 JP JP2015502383A patent/JP6348480B2/ja not_active Expired - Fee Related
- 2013-04-02 CN CN201380018498.8A patent/CN104582689A/zh active Pending
- 2013-04-02 CA CA2867638A patent/CA2867638A1/fr not_active Abandoned
- 2013-04-02 MX MX2014011789A patent/MX357927B/es active IP Right Grant
- 2013-04-02 IN IN7927DEN2014 patent/IN2014DN07927A/en unknown
- 2013-04-02 WO PCT/EP2013/056945 patent/WO2013144374A1/fr not_active Ceased

Also Published As

Publication number	Publication date
JP2015524913A (ja)	2015-08-27
EP2830592A1 (fr)	2015-02-04
JP6348480B2 (ja)	2018-06-27
MX2014011789A (es)	2015-06-03
US20150064794A1 (en)	2015-03-05
BR112014024256A2 (fr)	2017-06-20
MX357927B (es)	2018-07-27
WO2013144374A1 (fr)	2013-10-03
BR112014024256A8 (pt)	2018-02-06
CA2867638A1 (fr)	2013-10-03
KR20140144255A (ko)	2014-12-18
CN104582689A (zh)	2015-04-29
EP2645099A1 (fr)	2013-10-02
NZ700064A (en)	2016-08-26

Publication	Publication Date	Title
IN2014DN07927A (fr)	2015-05-01
Dubois-Brissonnet et al.	2016	The biofilm lifestyle involves an increase in bacterial membrane saturated fatty acids
WO2012125937A3 (fr)	2012-11-15	Enzymes glycosyl hydrolase et leurs utilisations pour une hydrolyse de la biomasse
MY160275A (en)	2017-02-28	Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
GB201212223D0 (en)	2012-08-22	Electrical connectors
NZ747847A (en)	2023-06-30	Lipid compositions
MA35195B1 (fr)	2014-06-02	Compositions lipidiques algales, leurs procédés de préparation et leurs utilisations
RU2010129985A (ru)	2012-01-27	Композиции питательного порошка и детской питательной смеси (варианты)
IN2014DN03449A (fr)	2015-06-05
AR077860A1 (es)	2011-09-28	Productos horneados de humedad intermedia y larga vida
ATE493893T1 (de)	2011-01-15	Feste enymformulierungen und verfahren zu deren herstellung
ATE524978T1 (de)	2011-10-15	Zusammensetzung zur reduzierung des nacl-gehaltes in lebensmitteln
BR112013032595A2 (pt)	2017-01-17	produtos para o consumidor com partículas revestidas que compreendem lipase
WO2012032416A3 (fr)	2012-05-03	Émulsions comestibles
WO2014088830A3 (fr)	2015-07-16	Criblage d'agents de type acide nucléique par exposition de particules
PH12013501337A1 (en)	2018-03-21	Novel preparation of an enteric release system
WO2012028526A3 (fr)	2012-10-18	Tétranectine-apolipoprotéine a-i, particules lipidiques la contenant et son utilisation
PH12019502410A1 (en)	2020-10-19	Encapsulated nutritional and pharmaceutical compositions
MX355131B (es)	2018-04-06	Emulsion de aceite en agua estable al calor.
EP2613636A4 (fr)	2014-01-22	Supplément alimentaire et procédés pour l'utiliser
MX2011007222A (es)	2011-08-08	Composicion nutricional para infantes.
WO2005112891A3 (fr)	2006-05-04	Compositions de facteur de transfert encapsulées et procédé d'utilisation
CL2009001888A1 (es)	2010-09-21	Formula nutricional que tiene un ph en el estado liquido de 4,8 a 5,2, que comprende 1 a 1,2% de acido lactico y entre 0,9 a 1,4% de una sal de acido lactico, seleccionada de lactato de sodio, de potasio o de calcio.
DK1815751T3 (da)	2010-08-30	Fuglefoder
CL2010000391A1 (es)	2010-09-03	Producto liofilizado en polvo para biolixiviacion o biooxidacion de minerales mixtos o puros que comprende consorcio microbiano de microorganismos nativos y/o modificados geneticamente que lixivian u oxidan los minerales, y/o compuestos de nutrientes especificos para el consorcio; su metodo de preparacion; y su metodo de aplicacion.